Mitch Higashi, PhD Joins ISPOR as Associate Chief Science Officer

Published Dec 11, 2023

Lawrenceville, NJ, USA—December 11, 2023—ISPOR—The Professional Society for Health Economics and Outcomes Research announced today that Mitch Higashi, PhD has joined the Society’s leadership team as Associate Chief Science Officer. In this role Dr Higashi will contribute to the development and deployment of ISPOR’s science and content strategies. He will also collaborate with the Society’s members, groups, stakeholders, and staff to advance initiatives that lead to increased awareness, understanding, and application of HEOR around the world.

Dr Higashi has more than 20 years’ experience in the field of HEOR. Most recently he served as Senior Vice President, HEOR at GeneDx. Previously he was Vice President, HEOR at Bristol-Myers Squibb and has worked in related roles at GE Healthcare and GlaxoSmithKline. Dr Higashi earned his PhD in health economics and outcomes research at the University of Washington. He has been an active member at ISPOR during his career, serving on the Society’s Health Science Policy Council from 2012 – 2017 and most recently as an ISPOR 2023 conference committee co-chair.

“We are thrilled to have Dr Higashi join ISPOR’s staff as our new Associate Chief Science Officer,” stated Chief Science Officer, Laura Pizzi, PharmD, MPH. “Mitch brings significant senior-level leadership experience in HEOR and has a depth of scientific experience and passion that makes him an ideal leader for this role. As the need for HEOR increases worldwide along with its use to inform the challenges of healthcare affordability and access, Mitch’s expertise is pivotal to moving ISPOR’s agenda—and our science—forward.”

Dr Higashi stated, “I am honored to be joining ISPOR at this critical juncture as HEOR moves to the forefront of healthcare decision making globally.”

###

 

ABOUT ISPOR
ISPOR—The Professional Society for Health Economics and Outcomes Research
(HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field.
Website
 | LinkedIn  | Twitter (@ispororg)  |  YouTube  |  Facebook  |  Instagram  

Related Stories

ISPOR Global Panel Proposes New Structure to Improve Definitions of Digital Health Interventions

Apr 9, 2024

ISPOR—The Professional Society for Health Economics and Outcomes Research announced today the publication of a report from the ISPOR Digital Health Special Interest Group that proposes a new framework to help standardize and clarify definitions used for digital health interventions. The report, “The PICOTS-ComTeC Framework for Defining Digital Health Interventions: An ISPOR Special Interest Group Report” was published in the April 2024 issue of Value in Health.

ISPOR Launches HEOR by Topic Microsite

Apr 2, 2024

ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR) announced that it has launched a new microsite that provides HEOR information and resources organized by topical areas of interest—HEOR by Topic.

ISPOR International Panel Calls for Consensus on Medication Adherence Measures

Feb 26, 2024

ISPOR—The Professional Society for Health Economics and Outcomes Research announced the publication of a new report from the ISPOR Medication Adherence and Persistence Special Interest Group revealing significant inconsistencies in how researchers measure the effectiveness of interventions aimed at improving medication adherence. The report, “A Systematic Review of Outcomes for Assessment of Medication Adherence Enhancing Interventions: An ISPOR Special Interest Group Report” was published in the February 2024 issue of Value in Health.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×